Synovus assumed with a Buy at UBS

UBS assumed coverage of Synovus (SNV) with a Buy rating and $76 price target UBS expects Synovus’s revenues to return to meaningful growth in 2025, and thinks net interest income tailwinds should materialize from continued fixed asset repricing, maturing swaps, and growth in its middle-market and CIB businesses, helping offset an asset-sensitive balance sheet, the analyst tells investors in a research note. The firm says Synovus is a bank to own over the next few years.